Daily Cardiology Research Analysis
Today’s most impactful cardiology papers include: (1) the 2025 ACC/AHA hypertension guideline update, providing a living, comprehensive synthesis to guide prevention, detection, evaluation, and management; (2) a prospective CMR study showing right ventricular longitudinal strain and left atrial reservoir strain as strong early markers for HFpEF against an invasive gold standard; and (3) an ultrasound radiomics (ultrasomics) study demonstrating robust, externally validated machine-learning detect
Summary
Today’s most impactful cardiology papers include: (1) the 2025 ACC/AHA hypertension guideline update, providing a living, comprehensive synthesis to guide prevention, detection, evaluation, and management; (2) a prospective CMR study showing right ventricular longitudinal strain and left atrial reservoir strain as strong early markers for HFpEF against an invasive gold standard; and (3) an ultrasound radiomics (ultrasomics) study demonstrating robust, externally validated machine-learning detection of acute myocardial infarction.
Research Themes
- Hypertension guideline update and clinical implementation
- Advanced cardiac imaging biomarkers for early HFpEF diagnosis
- AI-based ultrasomics for myocardial infarction detection
Selected Articles
1. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
This ACC/AHA-led guideline replaces the 2017 version, synthesizing human evidence from multiple databases into a continuously updated clinical guidance for adult hypertension across prevention, detection, evaluation, and management. It is intended as a living resource for both primary care and specialists.
Impact: Major guideline updates directly shape clinical practice and quality metrics in hypertension care. The living-document approach enhances timeliness and implementation.
Clinical Implications: Provides updated, comprehensive recommendations to standardize BP screening, risk assessment, and therapeutic strategies, enabling guideline-concordant care and system-level quality improvement.
Key Findings
- Retires and replaces the 2017 ACC/AHA adult hypertension guideline.
- Conducted a comprehensive evidence review (Dec 2023–Jun 2024) across MEDLINE, EMBASE, Cochrane, AHRQ, and other databases for human studies since Feb 2015.
- Establishes a living clinical practice guideline aimed at primary care and specialty clinicians managing hypertension.
Methodological Strengths
- Comprehensive, multi-database literature search covering recent evidence
- Consensus-driven guideline development by multidisciplinary societies
Limitations
- Specific recommendation details are not enumerated in the abstract
- Guideline implementation and updates depend on continuous evidence monitoring and timely revisions
Future Directions: Ongoing iterative updates as new evidence emerges; evaluation of real-world implementation and health equity impact.
AIM: The "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults" retires and replaces the "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults." METHODS: A comprehensive literature search was conducted from December 2023 to June 2024 to identify clinical studies, reviews, and other evidence performed on human subjects that were published since February 2015 in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: The focus of this clinical practice guideline is to create a living, working document updating current knowledge in the field of high blood pressure aimed at all practicing primary care and specialty clinicians who manage patients with hypertension.
2. Comprehensive cardiac magnetic resonance assessment of right ventricular and left atrial function for early diagnosis of heart failure with preserved ejection fraction.
In a two-center prospective cohort using iCPET as the diagnostic reference, CMR-derived RV longitudinal strain and LA reservoir strain achieved the highest accuracy for identifying HFpEF, with notable sex differences in LA strain performance. Strain abnormalities correlated with reduced exercise capacity and higher exercise PCWP.
Impact: Introduces robust, noninvasive CMR strain biomarkers benchmarked against an invasive gold standard, enabling earlier and more precise HFpEF diagnosis.
Clinical Implications: Integrating RV and LA strain into diagnostic workflows may improve early HFpEF detection and guide personalized management, with attention to sex-specific performance.
Key Findings
- CMR-derived RV longitudinal strain and LA reservoir strain had the highest diagnostic accuracy for HFpEF (AUC 0.805 and 0.776).
- LA reservoir strain showed sex-specific performance (AUC 0.801 in males vs 0.559 in females).
- Strain impairments correlated with reduced exercise capacity and higher exercise PCWP, indicating clinical relevance.
Methodological Strengths
- Prospective two-center cohort with invasive iCPET gold standard for HFpEF confirmation
- Comprehensive CMR assessment linking strain metrics to exercise physiology
Limitations
- Modest sample size with potential limitations for subgroup (sex) analyses
- Cross-sectional imaging relative to exercise measures; external validation needed
Future Directions: Prospective validation across diverse populations; standardization of strain thresholds; evaluation of clinical decision pathways incorporating strain metrics.
OBJECTIVES: To investigate the role of right ventricular (RV) maladaptive response to increased afterload in the early diagnosis of heart failure with preserved ejection fraction (HFpEF) using cardiac magnetic resonance (CMR) and invasive cardiopulmonary exercise testing (iCPET). This study evaluates biventricular function and its association with exercise performance in HFpEF. MATERIALS AND METHODS: We prospectively recruited 145 patients with suspected HFpEF from two centers, of whom 113 underwent echocardiography, iCPET, and CMR. Patients met the 2016 European Society of Cardiology HFpEF criteria, with iCPET confirming HFpEF as a pulmonary capillary wedge pressure (PCWP) > 15 mmHg at rest and > 25 mmHg at peak exercise. The diagnostic performance of CMR parameters was assessed using the area under the curve (AUC). RESULTS: Among the 113 patients, 72 had HFpEF (68 ± 10 years) and 41 were non-HFpEF (66 ± 11 years). HFpEF patients exhibited significantly reduced resting pulmonary artery compliance. CMR-derived RV longitudinal strain and left atrial (LA) reservoir strain had the highest diagnostic accuracy for HFpEF (AUC 0.805 and 0.776, respectively). A sex disparity was observed in the LA reservoir strain's diagnostic performance, with higher accuracy in males (AUC 0.801) compared to females (AUC 0.559). Additionally, impaired LA reservoir and booster strains, correlated with reduced exercise capacity and increased PCWP during exercise, highlighting their clinical relevance. CONCLUSIONS: RV systolic dysfunction and impaired LA strain serve as early HFpEF markers. The more pronounced LA dysfunction in males suggests potential sex-specific differences, underscoring the need to integrate RV and LA strain assessment into HFpEF diagnostics and personalized treatment approaches. KEY POINTS: Question Can cardiac MRI (CMR)-derived RV strain and LA reservoir strain improve the early diagnosis of HFpEF in symptomatic patients with preserved ejection fraction? Findings CMR-derived RV longitudinal strain and LA reservoir strain effectively differentiate early HFpEF; diagnostic accuracy of LA strain varies significantly by sex. Clinical relevance CMR-based RV and LA strain measurements enhance early HFpEF detection, with higher diagnostic accuracy in males, supporting sex-specific diagnostic strategies for timely and personalized heart failure care.
3. Ultrasonic Texture Analysis for Predicting Acute Myocardial Infarction.
Across three independent sources with leave-one-source-out external validation, an ultrasomics ML model achieved AUC 0.87 for MI detection and provided additive value beyond global longitudinal strain. ML probability remained an independent predictor after adjustment for conventional echo.
Impact: Demonstrates a practical, noninvasive, and generalizable AI approach using standard echo views to detect MI, potentially expediting diagnosis where advanced imaging is unavailable.
Clinical Implications: Ultrasomics could augment echocardiography-based triage and MI detection, especially when strain analysis is limited, improving diagnostic workflows and resource allocation.
Key Findings
- ML ultrasomics achieved AUC 0.87 (95% CI: 0.84–0.89) for MI, outperforming transfer learning-based deep features (AUC 0.74).
- ML probability independently predicted MI after adjusting for conventional echo metrics (adjusted OR 1.03; P < 0.0001).
- Combining ML probability with global longitudinal strain improved performance over strain alone (AUC 0.86 vs 0.80; P = 0.02).
Methodological Strengths
- Multisource dataset with leave-one-source-out external validation
- Comparison of handcrafted features vs transfer learning deep features with rigorous statistics
Limitations
- Potential heterogeneity across scanners and vendors; prospective real-time clinical validation is needed
- Model interpretability and workflow integration require further study
Future Directions: Prospective interventional studies to assess clinical impact on triage and outcomes; harmonization across vendors; explainability tools to support adoption.
BACKGROUND: Acute myocardial infarction (MI) alters cardiomyocyte geometry and architecture, leading to changes in the acoustic properties of the myocardium. OBJECTIVES: This study examines ultrasomics-a novel cardiac ultrasound-based radiomics technique to extract high-throughput pixel-level information from images-for identifying ultrasonic texture and morphologic changes associated with infarcted myocardium. METHODS: The authors included 684 participants from multisource data: a) a retrospective single-center matched case-control dataset; b) a prospective multicenter matched clinical trial dataset; and c) an open-source international and multivendor dataset. Handcrafted and deep transfer learning-based ultrasomics features from 2- and 4-chamber echocardiographic views were used to train machine learning (ML) models with the use of leave-one-source-out cross-validation for external validation. RESULTS: The ML model showed a higher AUC than transfer learning-based deep features in identifying MI (AUC: 0.87 [95% CI: 0.84-0.89] vs AUC: 0.74 [95% CI: 0.70-0.77]; P < 0.0001). ML probability was an independent predictor of MI even after adjusting for conventional echocardiographic parameters (adjusted OR: 1.03 [95% CI: 1.01-1.05]; P < 0.0001). ML probability showed diagnostic value in differentiating acute MI, even in the presence of myocardial dysfunction (averaged longitudinal strain [LS] <16%) (AUC: 0.84 [95% CI: 0.77-0.89]). In addition, combining averaged LS with ML probability significantly improved predictive performance compared with LS alone (AUC: 0.86 [95% CI: 0.80-0.91] vs AUC: 0.80 [95% CI: 0.72-0.87]; P = 0.02). Visualization of ultrasomics features with the use of a Manhattan plot discriminated infarcted and noninfarcted segments (P < 0.001) and facilitated parametric visualization of infarcted myocardium. CONCLUSIONS: This study demonstrates the potential of cardiac ultrasomics to distinguish healthy from infarcted myocardium and highlights the need for validation in diverse populations to define its role and incremental value in myocardial tissue characterization beyond conventional echocardiography.